Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task-Reference-Cited by-同舟云学术

Potential cognitive actions of (n-propargly-(3r)-aminoindan-5-yl)-ethyl, methyl carbamate (tv3326), a novel neuroprotective agent, as assessed in old rhesus monkeys in their performance of versions of a delayed matching task

Published:2003-07 Issue:3 Volume:119 Page:669-678
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Buccafusco J.J,Terry A.V,Goren T,Blaugrun E

Publisher

Elsevier BV

Subject

General Neuroscience

Reference33 articles.

1. The neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkey;Andringa;J Neural Trans Suppl,2000

2. The contribution of α2-noradrenergic mechanisms of prefrontal cortical cognitive function;Arnsten;Arch Gen Psychiatry,1996

3. On neurodegenerative diseases, models, and treatment strategies;Bartus;Exp Neurology,2000

4. Neuropharmacologic and behavioral actions of clonidine;Buccafusco;Int Rev Neurobiol,1992

5. Effects of concomitant cholinergic and adrenergic stimulation on learning and memory performance by primates;Buccafusco;Life Sci,1992

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in prodrug design for Alzheimer’s disease: the state of the art;Expert Opinion on Drug Discovery;2022-02-23

2. A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review;European Journal of Medicinal Chemistry;2020-11

3. Exploring the Multifunctional Neuroprotective Promise of Rasagiline Derivatives for Multi-Dysfunctional Alzheimer’s Disease;Current Pharmaceutical Design;2020-10-26

4. TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s-like neuropathology;Journal of Pharmacy and Pharmacology;2020-03-09

5. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders;Drug Discovery Today;2016-12